IMVT vs MSFT: Which Stock is Better?
Side-by-side comparison of Immunovant Inc and Microsoft Corporation in 2026
IMVT
Immunovant Inc
$39.90
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | IMVT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.90B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze IMVT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IMVT or MSFT a better investment?
Comparing IMVT and MSFT: Immunovant Inc has a market cap of $2.90B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IMVT and MSFT?
IMVT (Immunovant Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IMVT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IMVT or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for IMVT.
Which company is more profitable: IMVT or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for IMVT.
Which is the larger company: IMVT or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.90B for IMVT.
Should I buy IMVT or MSFT in 2026?
Both IMVT and MSFT have investment merit. IMVT trades at $39.90 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IMVT and MSFT stock?
Key differences: Market Cap ($2.90B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy IMVT or MSFT in 2026?
The choice between IMVT and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between IMVT and MSFT?
IMVT (Immunovant Inc) has a market cap of $2.90B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.